Amide Technologies

Amide Technologies is a biotechnology company specializing in the rapid chemical synthesis of complex peptides and proteins. Spun out from the Massachusetts Institute of Technology (MIT), the company utilizes a proprietary fast-flow peptide synthesis platform that significantly reduces the time required to produce high-quality, long-chain peptides. This technology enables the production of synthetic proteins and modified biologics that are often challenging to manufacture using recombinant methods. Amide Technologies serves the pharmaceutical and research sectors by providing custom synthesis services and collaborating on the development of next-generation peptide-based therapeutics. Their platform allows for the precise incorporation of non-natural amino acids and site-specific modifications, expanding the chemical space available for drug discovery. The company is headquartered in Cambridge, Massachusetts, and maintains strong ties to the academic research community.